Siemens Healthineers has announced the CE marking of its Neurofilament Light Chain (NfL) assay for multiple sclerosis (MS) management. Developed in collaboration with Novartis Pharma AG, this blood test is designed for use on the Atellica IM Analyzer and the ADVIA Centaur XP/XPT Systems.
Bio-Rad Laboratories has expanded its portfolio of molecular quality controls with the introduction of Exact Diagnostics GBS Positive and Negative Run Controls. These new products complement the previously launched Exact Diagnostics GBS Verification & Validation Panel, offering clinical laboratories a comprehensive solution for Group B Streptococcus (GBS) molecular assay quality management.
The UNIQO 160, an advanced automation system for indirect immunofluorescence assays (IFA), now incorporates AI-based evaluation of results. This innovation enables complete walkaway automation from primary sample to result proposal, significantly enhancing efficiency and standardisation in IFA analysis.
UK-based toxicology specialist Contract Research Organisation (CRO) Gentronix has been awarded the prestigious King’s Award for Enterprise for 2024 in recognition of its remarkable international trade performance. The Alderley Park-based firm has demonstrated exceptional growth in overseas earnings, with a 239% increase over the past three years.
UK-based biotechnology firm Nuclera has been awarded two Innovate UK grants totalling £1.14 million to further develop its eProtein Discovery system. The funding comprises a £790,000 flexible, agile, scalable, and sustainable technologies (FASST) grant and a £350,000 Engineering Biology grant.
The Celonic Group, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in quality biologics, has inaugurated its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This expansion aims to support pharmaceutical companies in developing and optimising processes using advanced bioprocessing technologies.
SGS, a leading provider of biopharmaceutical testing services, has announced the expansion of its laboratory in Birsfelden, Switzerland, to include stability studies. This addition to the facility’s service portfolio aims to meet the growing demand for comprehensive and reliable stability testing in the biopharmaceutical industry.
Icosagen, a contract research, development, and manufacturing organisation (CRDMO) specialising in innovative antibody research and production, has announced a strategic partnership with Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor (GPCR), which are often challenging […]
Leading contract development and manufacturing organisation (CDMO) Vetter has announced significant expansion plans in both the United States and Germany, aiming to meet the growing demand for outsourced development and manufacturing of injectable medications.
The European Laboratory Research & Innovation Group (ELRIG) UK has revealed the keynote speakers for its flagship conference, Drug Discovery 2024. The event, scheduled for 2-3 October at ExCeL London, will feature presentations from two distinguished scientists in the field of pharmaceutical research and development.
February | March 2025
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.